⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
T. ROWE PRICE EXPLORES LEADERSHIP AND INNOVATION IN AN INCREASINGLY COMPLEX NATIONAL SECURITY LANDSCAPE WITH NORTHROP GRUMMAN CEO KATHY WARDEN
prnewswire.com
TROW
NOC
GE
NYT
ISRG
NVDA
XOM
LLY
TMUS
F
Strengthen Readiness for a Potential SAS-to-R Shift in Data Analytics, Upcoming Webinar Hosted by Xtalks
prnewswire.com
LLY
Cirius Therapeutics Announces Gestational Diabetes Initiative
prnewswire.com
ZTS
LLY
AMGN
Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape
globenewswire.com
UCB
AZN
LLY
PFE
ABBV
REGN
AMGN
BMY
SNY
JNJ
TLRY
FuturHealth Among the First to Offer Eli Lilly's Oral GLP-1, Orforglipron, Expanding Access to Next-Generation, Non-Injectable Treatment
prnewswire.com
LLY
Continuous Manufacturing Systems Market Size Expected to Reach USD 2148.06 Mn at 12.04% CAGR by 2034
globenewswire.com
MRK
PFE
LLY
AMGN
GSK
Axial Spondyloarthritis Management Market to Reach USD 8.06 Billion by 2035, Driven by Biologic Innovation and Rising Demand for Personalized Care | Future Market Insights (FMI)
accessnewswire.com
ABBV
PFE
AMGN
JNJ
LLY
HRZN
Penn Dental Medicine Study Investigates Plant-encapsulated Delivery Platform for Oral Delivery of GLP-1 Drugs
prnewswire.com
NVO
LLY
U.S. Pharmaceutical Market to Reach USD 965 Billion by 2035
globenewswire.com
ABT
BIIB
BMY
GILD
GSK
LLY
MRK
NVS
NVO
PFE
SNY
FormBlends Publishes 2026 State of Peptides Report as RFK-Era HHS Signals Major Shifts for GLP-1 and Peptide Therapy Access in the United States
globenewswire.com
LLY
NVO
BMY
AMGN
AZN
PFE
ALT